3647 results for «645»
3647 results
EuroPCR 2017 Nurses and Allied Professionals Programme Closing Ceremony
19 May 2017 – From EuroPCR 2017
Consult the session on the Closing Ceremony of the EuroPCR 2017 Nurses and Allied Professionals Programme, presented by S. Coelho, H. Eltchaninoff and D. Sparv. The State-of-the-art lecture on structural heart disease by Prof. A. Cribier sheds light on LAA occlusion.
EuroPCR 2018 Opening Ceremony and Ethica Awards
22 May 2018 – From EuroPCR 2018
Join J. Fajadet and W. Wijns for the EuroPCR 2018 Opening Ceremony and find out who this year's Ethica Awards winners are!
EuroPCR 2018 Closing Ceremony
25 May 2018 – From EuroPCR 2018
Consult the session video on the Closing Ceremony of EuroPCR 2018 presented by A. Baumbach.
Nurses and Allied Professionals Best Abstract and Clinical Case Awards and Closing Ceremony
24 May 2018 – From EuroPCR 2018
Consult this session to see best abstract and clinical case awards for nurses and allied professionals at EuroPCR 2018.
Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism: primary outcomes from the PEERLESS randomized controlled trial
30 Oct 2024
Elad Asher provides his take on the PEERLESS trial presented by Wissam A. Jaber at TCT 2024 in Washington.
Author
How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI
29 Jan 2026
Large-bore femoral access closure remains a critical step in transfemoral TAVI, where access-site complications can significantly impact outcomes.
This My Toolkit article presents a step-by-step tutorial on a combined suture- and plug-based closure strategy using one ProStyle™ and one Angio-Seal®. The technique aims to achieve rapid, reliable...
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
